Skip to main content
SpringerLink
Log in

Antineoplastics

Posterior reversible encephalopathy syndrome, grade 3 oral ulcer and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zou X, et al. Posterior reversible encephalopathy syndrome after anlotinib treatment for small cell lung cancer: A case report and literature review. Frontiers in Pharmacology 14: 1-8, et al. Feb 2023. Available from: URL: http://www.frontiersin.org/Pharmacology

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1957, 49 (2023). https://doi.org/10.1007/s40278-023-39174-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-39174-3

Search

Navigation